Cite
HARVARD Citation
Sasi, A. et al. (2022). Doxorubicin plus trabectedin for metastatic or unresectable leiomyosarcoma. Lancet oncology. 23 (10), pp. e442-. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Sasi, A. et al. (2022). Doxorubicin plus trabectedin for metastatic or unresectable leiomyosarcoma. Lancet oncology. 23 (10), pp. e442-. [Online].